Calculating reading ease score of patient package inserts in Iran
- PMID: 29593437
- PMCID: PMC5863713
- DOI: 10.2147/DHPS.S150428
Calculating reading ease score of patient package inserts in Iran
Abstract
Background: The patient package inserts (PPIs), which contain the necessary information about medications intended for patients, need to be expressed in a clear language comprehensible to everyone.
Objective: This study aimed to evaluate the readability and understandability of the drug package inserts for the inexpert people.
Methods: The readability of the 158 PPIs of the 33 drugs, registered and manufactured in Iran, was calculated. The main criterion for selecting PPIs to include in this study was of those top-selling drugs during the year 2015 according to the Social Security Organization in Iran. The PPIs were collected from the pharmacies of the three major cities, namely, Tabriz, Ardabil and Meshgin Shahr. Then, using the Flesch-Dayani readability (FDR) tool adjusted for the Persian language, the average number of the words and syllables was counted to calculate and grade the readability score of the selected PPIs.
Results: This study showed that the average FDR readability score for all the 33 drugs is 52.52, which are graded 10th-11th. Of the PPIs, 70.89% were difficult to read, and on average, the readability of the PPIs was five times difficult than the standard ones. Only 13.92% PPIs were suitable for the 5th-7th grade, and 15.19% of the package inserts ranked in the 8th-9th reading grade.
Conclusion: A considerable number of the PPIs in Iran have low readability level and were not suitable for the inexpert readers. Since the treatment cost is very high, people tend to use medications arbitrarily or simply use old prescriptions. This study suggests the necessity of a major improvement in the readability level of the PPIs in order to ensure the usefulness of the PPIs to the majority of the consumers.
Keywords: Flesch–Dayani indicator; Flesch–Dayani readability; drug guide; drug package insert; leaflet; patient package inserts; pharmaceutical brochures; readability.
Conflict of interest statement
Disclosure The authors report no conflicts of interest in this work.
References
-
- Singh KR, Munshi R, Arora D. Assessment of the degree of awareness among physicians and patients about drug package inserts. Int J Pharm Sci Res. 2016;7(3):1338.
-
- Vander Stichele RH. Impact of written drug information in patient package inserts Acceptance and benefit/risk perception. Gent: Academia Press Scientific Publishers; 2004.
-
- Dass AS, Sarala N, Bhuvana K. Analysis of package inserts of drugs utilized in a tertiary care hospital. J Young Pharm. 2016;8(3):275.
-
- Gupta V, Pathak S. Assessment of awareness and knowledge about package inserts amongst medical students: a questionnaire based study. IOSR J Pharm. 2012;2(2):215–217.
-
- Piñero-López MÁ, Modamio P, Lastra CF, Mariño EL. Readability assessment of package inserts of biological medicinal products from the European medicines agency website. Drug Saf. 2014;37(7):543–554. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
